NDC product
LUCEMYRA
NDC 85789-801 · BioCorRx Pharmaceuticals Inc
Key facts
| Product NDC | 85789-801 |
|---|---|
| Proprietary name | LUCEMYRA |
| Nonproprietary name | lofexidine hydrochloride |
| Substances | LOFEXIDINE HYDROCHLORIDE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | BioCorRx Pharmaceuticals Inc |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA209229 |
| Marketing start | Aug 15, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: